Non-vascular Stents Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Non-vascular Stents Market Analysis
The non-vascular stents market studied is anticipated to grow with a CAGR of nearly 5.2%, during the forecast period.
COVID-19 is expected to have a significant impact on the growth of the market during the pandemic period. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. According to the article published in the National Institute of Health in October 2021, titled " The impact of COVID-19 on emergency general surgery admissions and operative volumes: A single-center experience," there has been a 42.8% decline in general surgery admission across the globe. Thus the non-vascular stents devices market has been significantly impacted by COVID-19.
Certain factors that are driving the market growth include the growing geriatric population and the prevalence of chronic and other diseases, and technological developments in non-vascular stents. According to the International Foundation for Gastrointestinal Disorders 2022 updates, it's estimated that 5-10% of the population has inflammatory bowel disease worldwide. Gastroenterologist visits in the United States were found to be 2.4 to 3.5 million yearly. Such factors are likely to boost the adoption of nonvascular stents, thereby contributing to the growth of the market.
According to the World Health Organization (WHO) data published in October 2021, By 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the aging population increases the demand for non-vascular stents as the geriatric population are prone to developing chronic diseases.
Thus the rising prevalence of various diseases is expected to boost the rise in demand for non-vascular stents.
Non-vascular Stents Market Trends
This section covers the major market trends shaping the Non-Vascular Stents Market according to our research experts:
Urological Stents Dominate the Global Non-vascular Stents Market Over the Forecast Period
The key factors propelling the segment growth include a high incidence of urologic conditions, a rising senior population, and technological advancements.
According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIs), and kidney and ureteral stones are among the most common urological diseases. The United States According to the National Institute of Medicine July 2020, urinary tract infection affects approximately 150 million people globally. In addition, about 11% of women visit one physician yearly for urinary tract infection treatment. Urinary tract infections (UTIs) are among the most common microbial diseases affecting people of all ages. Diabetic patients have a higher risk of developing UTIs. With a global increase in the diabetic population, complications like dysuria and organ damage are associated with UTIs, which are also rising.
Additionally, according to an article published in the International Journal of Molecular medicine in August 2020, Kidney stone disease, also known as nephrolithiasis or urolithiasis, is one of medicine's oldest diseases. It is estimated that 11% of people will develop kidney stones at some point in their lives, and the prevalence and incidence of kidney stones are increasing worldwide. However, the overall prevalence of urolithiasis was 11.2 %, with 48.8 % having a first-degree relative with the disease. Males were 1.8 times more likely than females to have urolithiasis.
Thus the above mentioned factors are expected to drive the growth of the studied segment during the forecast period.
North America Dominates the Global Non-vascular Stents Market Over the Forecast Period
The rising disease prevalence is propelling the market growth across the entire region. For instance, abdominal wall hernias are among the most common of all surgical problems. Knowledge of these hernias (usual and unusual) and of protrusions that mirror them is an essential component of the armamentarium of the general and pediatric surgeon.
The article titled " New machine learning models can predict adverse outcomes following abdominal hernia surgery with high accuracy" published in April 2022 mentioned that 4 million abdominal operations are performed in the United States each year, some of which may reuire the need for hernia repair. More than 400,000 ventral hernia repair operations are performed annually. According to the estimates of the American Cancer Society, in 2020, there were around 73,750 new cases of kidney cancer in the United States and approximately 14,830 deaths from this disease.
These rising rates of emergent incisional hernia repair are bothersome owing to the significantly increased risk of morbidity and mortality, thus generating a need for non-vascular stents such as gastrointestinal stents, in the region.
Thus the above mentioned factors are expected to drive the growth of the market over the forecast period in this region.
Non-vascular Stents Industry Overview
The non-vascular stents market is competitive and consists of a few major players. Companies like Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Medical, ELLA - CS, s.r.o., Glaukos Corporation, Hobbs Medical., Medtronic, Micro-Tech (Nanjing) Co. Ltd, W. L. Gore & Associates Inc., among others, hold the substantial market share in the market.
Non-vascular Stents Market Leaders
-
Medtronic
-
Becton, Dickinson and Company
-
Boston Scientific Corporation
-
ELLA - CS, s.r.o.
-
CONMED Corporation
*Disclaimer: Major Players sorted in no particular order
Non-vascular Stents Market News
- In October 2022, Boston Scientific Corporation received CE mark approval for expanded indication of WallFlex Biliary RX fully covered stent for the treatment of benign biliary structures.
- In May 2021, ivascular received CE mark approval for the iCover stent. Ballon-expandable covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries, and for the treatment of aneurysms and ruptures.
Non-vascular Stents Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Geriatric Population and Prevalence of Chronic and Other Diseases
- 4.2.2 Technological Developments in Non-Vascular Stents
-
4.3 Market Restraints
- 4.3.1 Complications Associated with Non-Vascular Stents
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product Type
- 5.1.1 Gastrointestinal Stents
- 5.1.2 Pulmonary (Airway) Stents
- 5.1.3 Urological Stents
- 5.1.4 Others
-
5.2 By Material Type
- 5.2.1 Metallic Stents
- 5.2.2 Non-metallic Stents
-
5.3 By End-User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centers
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Becton, Dickinson and Company
- 6.1.2 Boston Scientific Corporation
- 6.1.3 CONMED Corporation
- 6.1.4 Cook Medical
- 6.1.5 ELLA - CS, s.r.o.
- 6.1.6 Glaukos Corporation
- 6.1.7 Hobbs Medical
- 6.1.8 Medtronic
- 6.1.9 Micro-Tech (Nanjing) Co. Ltd
- 6.1.10 W. L. Gore & Associates Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNon-vascular Stents Industry Segmentation
As per the scope, non-vascular stents refer to a family of devices for a variety of applications, including biliary, colonic, oesophageal, bronchial and tracheal implantations. The Non-vascular Stents Market is segmented by Product Type (Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stents, Others), Material Type (Metallic Stents, Non-metallic Stents), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | Gastrointestinal Stents | |
| Pulmonary (Airway) Stents | ||
| Urological Stents | ||
| Others | ||
| By Material Type | Metallic Stents | |
| Non-metallic Stents | ||
| By End-User | Hospitals | |
| Ambulatory Surgical Centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Non-vascular Stents Market Research FAQs
What is the current Global Non-vascular Stents Market size?
The Global Non-vascular Stents Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)
Who are the key players in Global Non-vascular Stents Market?
Medtronic, Becton, Dickinson and Company, Boston Scientific Corporation, ELLA - CS, s.r.o. and CONMED Corporation are the major companies operating in the Global Non-vascular Stents Market.
Which is the fastest growing region in Global Non-vascular Stents Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Non-vascular Stents Market?
In 2024, the North America accounts for the largest market share in Global Non-vascular Stents Market.
What years does this Global Non-vascular Stents Market cover?
The report covers the Global Non-vascular Stents Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Non-vascular Stents Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vascular Stents Industry Report
Statistics for the 2024 Vascular Stents market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vascular Stents analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
